Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

Oncogene

Volumn 18, Issue 3, 1999, Pages 643-650

  Wistuba, Ignacio I ^a,b   Behrens, Carmen ^a   Milchgrub, Sara ^a   Bryant, David ^a   Hung, Jaclyn ^a,c   Minna, John D ^a   Gazdar, Adi F ^a,d  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chromosome 3p; Chromosome 9p; Loss of heterozygosity; Lung carcinoma; Preneoplastic lesions; TP53 gene

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BRONCHUS MUCOSA; CARCINOMA IN SITU; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 9P; CLINICAL ARTICLE; DYSPLASIA; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; ALLELES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; EPITHELIUM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASMS, SQUAMOUS CELL;

BRONCHUS;

EID: 0033590626     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202349     Document Type: Article

References (42)

1. Adachi JI, Shiseki M, Okazaki T, Ishimuru G, Noguchi M, Hirohashi S and Yokota Y. (1995). Genes Chromosomes Cancer, 14, 301-306.
2. Band PR, Feldstein M and Saccomanno G. (1986). Cancer Detect. Prevent., 9, 157-160.
3. Birch DE. (1996). Nature, 381, 445-446.
4. Cawkwell L, Lewis FA and Quirke P (1994). Br. J. Cancer, 70, 813-818.
5. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R and Rabbitts PH. (1995). Oncogene, 11, 2591-2598.
6. Chung GTY, Sundaresan V, Hasleton P, Rudd R, Taylor R and Rabbitts PH. (1996). Cancer Res., 56, 1609-1614.
7. Colby TV, Koss MN and Travis WD. (1995). Tumors of the lower respiratory tract, 3rd series, Fascicle 13. Armed Forces Institute of Pathology, Washington, D.C.
8. Deng G, Lu Y, Zlotnikov G, Thor AD and Smith HS. (1996). Science, 274, 2057-2059.
9. Don RH, Cox PT, Wainwright BJ Baker K and Mattick JS. (1991). Nucleic Acids Res., 19, 4008.
10. Fishel R. (1996). J. Natl. Cancer Inst., 88, 1608-1609.
11. Fisher JC. (1958). Nature, 181, 651-652.
12. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader, SA, Ahmadian M, Tiong Ong S, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF and Minna JD. (1997). Cancer Res., 57, 2256-2267.
13. Fong KM, Zimmerman PV and Smith PJ. (1995). Cancer Res., 55, 28-30.
14. Franklin WA, Gasdar AF, Haney J, Wistuba H, La Rosa FG, Kennedy T, Ritchey DM and Miller YE. (1997). J. Clin. Invest., 100, 2133-2137.
15. Frost JK, Ball WJ, Levin ML, Tockman MS, Erozan YS, Gupta PK, Eggleston JC, Pressman NJ, Donithan MP and Kimball AJ. (1986). J. Occupat. Med., 28, 692-703.
16. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD and Gazdar AF. (1995). JAMA, 273, 558-563.
17. Jones MH and Nakamura Y. (1992). Genes Chromosomes Cancer, 5, 89-90.
18. Kishimoto Y, Sugio K, Mitsudomi T, Oyama T, Virmani A, McIntire DD and Gazdar AF. (1995). J. Natl. Cancer Inst., 87, 1224-1229.
19. Loeb LA. (1991). Cancer Res., 51, 3075-3079.
20. Loeb LA. (1994). Cancer Res., 54, 5059-5063.
21. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F and Sidransky D. (1994). Proc. Natl. Acad. Sci. USA, 91, 9871-9875.
22. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittleman WN and Hong WK. (1997). J. Natl. Cancer Inst., 89, 857-862.
23. Merlo A., Mabry M, Gabrielson E, Vollmer R, Baylin SB and Sidransky D. (1994). Cancer Res., 54, 2098-2101.
24. Minna JD, Sekido Y, Fong K and Gazdar AF. (1997). Cancer: Principles and Practice of Oncology, 5th edition. DeVita, Jr VT, Hellman S and Rosenberg SA (eds). Lippincott: Philadelphia, pp 849-857.
25. Miozzo M, Sozzi G, Musso K, Pilotti S, Incarbone M, Pastorino U and Pierotti MA. (1996). Cancer Res., 56, 2285-2288.
26. Nowell PC. (1976). Science, 194, 23-28.
27. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K. (1996). Cell, 84, 587-597.
28. Parker SL, Tong T, Bolden S and Wingo PA. (1997). CA Cancer J. Clin., 47, 5-27.
29. Parkin DM, Pisani P, Lopez AD and Masuyer E. (1994). Int. J. Cancer, 5904, 494-504.
30. Risse E, Vooijs G and van't Hof M. (1988). Acta Cytol., 32, 629-634.
31. Saccomanno G, Archer VE, Auerbach O, Saunders RP and Brennan LM. (1974). Cancer, 33, 256-270.
32. Siegel S. (1956). Nonparametric Statistics for the Behavioural Sciences. McGraw-Hill International Book Co, New York, NY.
33. Sozzi G, Veronese ML, Negrini M, Baffa R, Corticelli MG, Inoue H, Tornielli S, Pilotti S, Ohta M, Huebner K and Croce CM. (1996). Cell, 85, 17-26.
34. Strong MS, Incze J and Vaughan CW. (1984). J. Otolaryng., 13, 1-6.
35. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehan NM and Rabbitts P. (1992). Oncogene, 7, 1989-1997.
36. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, Paleic B and S, L. (1995). Cancer Res., 55, 5133-5139.
37. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW and Dryja TP. (1993). Genomics, 17, 535-543.
38. Vogelstein B. Fearon E.R, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R. (1989). Science, 244, 207-211.
39. Wistuba H, Behrens C, Milchgrub S, Virmani A, Jagirdar J, Thomas B, Ioachim HL, Litzky LA, Brambilla EM, Minna JD and Gazdar AF. (1998). JAMA, 279, 1554-1559.
40. Wistuba H, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD and Gazdar AF. (1997a). J. Natl. Cancer Inst., 89, 1366-1373.
41. Wistuba H, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C Minna JD and Gazdar AF. (1997b). Cancer Res., 57, 3154-3158.
42. Wistuba H, Sugio KH, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J and Gazdar AF. (1995). Cancer Res., 55, 2511-2515.